Microdosing may cause more harm than good: Doctor | Morning in America
Dr. Alexandra Sowa highlights the risks of microdosing Ozempic for benefits other than treating diabetes and losing weight.
WGN Radio12d
Ilyce Glink: We are making more money
Ilyce Glink, CEO of Best Money Moves financial wellness company, joins Lisa Dent to discuss recent statistics which indicate ...
India TV14d
US FDA approves Novo Nordisk's Ozempic to reduce risk of kidney diseases in diabetic patients
The US Food and Drug Administration (FDA) has approved Novo Nordisk's Ozempic to lower the risk of kidney failure and disease progression. According to a statement made by the Danish ...
6abc News15d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...
McKnight's Long-Term Care News15d
FDA expands Ozempic to treat kidney disease in people with diabetes
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure ...
WLKY15d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
THEY'RE ADVERTISED AS OZEMPIC OR WEGOVY. 12;40;15;00 THE GENERIC NAME IS SEMAGLUTIDE, THESE ARE IN A CLASS OF MEDICATIONS CALLED GLP1. DR. COHEN SAYS THIS IS A NATURALLY OCCURING HORMONE THAT CUES ...